Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

EVI1 dysregulation: impact on biology and therapy of myeloid malignancies
Christine Birdwell, Warren Fiskus, Tapan M. Kadia, et al.
Blood Cancer Journal (2021) Vol. 11, Iss. 3
Open Access | Times Cited: 48

Showing 26-50 of 48 citing articles:

Acute myeloid leukemia (AML) with chromosome 3 inversion: biology, management, and clinical outcome
Abdulrahman Alhajahjeh, Jan Philipp Bewersdorf, Rebecca P. Bystrom, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2024) Vol. 65, Iss. 11, pp. 1541-1551
Closed Access | Times Cited: 1
EVI1 Promotes the Proliferation and Invasive Properties of Human Head and Neck Squamous Cell Carcinoma Cells
Alexander M. Grandits, Sophie Bromberger, Gerwin Heller, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1050-1050
Open Access | Times Cited: 5
Preclinical efficacy of targeting epigenetic mechanisms in AML with 3q26 lesions and EVI1 overexpression
Christine Birdwell, Warren Fiskus, Tapan M. Kadia, et al.
Leukemia (2023) Vol. 38, Iss. 3, pp. 545-556
Closed Access | Times Cited: 2
Del(5q) and inv(3) in myelodysplastic syndrome: A rare case report
Haiping Liang, Xingchun Luo, Yali Zhang, et al.
World Journal of Clinical Cases (2022) Vol. 10, Iss. 11, pp. 3601-3608
Open Access | Times Cited: 3
AKT inhibition sensitizes EVI1 expressing colon cancer cells to irinotecan therapy by regulating the Akt/mTOR axis
Pradeepa, Voddu Suresh, Shantibhusan Senapati, et al.
Cellular Oncology (2022) Vol. 45, Iss. 4, pp. 659-675
Closed Access | Times Cited: 3
TGFβ Inhibitor A83-01 Enhances Murine HSPC Expansion for Gene Therapy
Jenni Fleischauer, Antonella Lucía Bastone, Anton Selich, et al.
Cells (2023) Vol. 12, Iss. 15, pp. 1978-1978
Open Access | Times Cited: 1
Precision Medicine Approaches in Acute Myeloid Leukemia with Adverse Genetics
Nicole Santoro, Prassede Salutari, Mauro Di Ianni, et al.
(2024)
Open Access
Orthogonal proteogenomic analysis identifies the druggable PA2G4-MYC axis in 3q26 AML
Matteo Marchesini, Andrea Gherli, Elisa Simoncini, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access
Clinical Significance of Dynamic Monitoring of EVI1 Gene Expression in Pediatric Acute Myeloid Leukemia
Lannan Zhang, Jianxin Li, Zhuo Wang, et al.
Research Square (Research Square) (2024)
Closed Access
Neuronal activity stimulates a genetic program to rapidly generate synapses during development

Nature Neuroscience (2024) Vol. 27, Iss. 9, pp. 1641-1642
Closed Access
MECOM Locus classical transcript isoforms affect tumor immune microenvironment and different targets in ovarian cancer
Ning Lan, Shuheng Bai, Min Chen, et al.
Journal of Ovarian Research (2024) Vol. 17, Iss. 1
Open Access
Next-generation sequencing RNA fusion panel for the diagnosis of haematological malignancies
T. Ngo, Anna Fong Na Goh, Pranav Dorwal, et al.
Pathology (2024) Vol. 57, Iss. 3, pp. 340-347
Closed Access
HMX3 is a critical vulnerability in MECOM-negative KMT2A::MLLT3 acute myelomonocytic leukemia
Saioa Arza-Apalategi, Branco M. H. Heuts, Saskia M. Bergevoet, et al.
Leukemia (2024)
Closed Access
Clinical significance of dynamic monitoring of EVI1 gene expression in pediatric acute myeloid leukemia
Lannan Zhang, Jianxin Li, Zhuo Wang, et al.
BMC Pediatrics (2024) Vol. 24, Iss. 1
Open Access
Evi1 governs Kdm6b-mediated histone demethylation to regulate the Laptm4b-driven mTOR pathway in hematopoietic progenitor cells
Qiong Wu, Chunjie Yu, Fang Yu, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 24
Open Access
Complex Genetic Evolution and Treatment Challenges in Myeloid Neoplasms: A Case of Persistent t(2;3)(p15~23;q26)/MECOMRearrangement,SF3B1Mutation, and TransientTNIP1::PDGFRBChimera
Kristin Andersen, Geir E. Tjønnfjord, Malu Lian Hestdalen, et al.
Cancer Genomics & Proteomics (2024) Vol. 22, Iss. 1, pp. 24-33
Open Access
Newly designed breakapart FISH probe helps to identify cases with true MECOM rearrangement in myeloid malignancies
Ming Zhao, L. Jeffrey Medeiros, Wei Wang, et al.
Cancer Genetics (2021) Vol. 262-263, pp. 23-29
Closed Access | Times Cited: 2
Cytogenetics analysis as the central point of genetic testing in acute myeloid leukemia (AML): a laboratory perspective for clinical applications
Aliaa Arina Rosli, Adam Azlan, Yaashini Rajasegaran, et al.
Clinical and Experimental Medicine (2022) Vol. 23, Iss. 4, pp. 1137-1159
Closed Access | Times Cited: 1
Secondary acute myeloid leukemia and de novo acute myeloid leukemia with myelodysplasia-related changes - close or complete strangers?
Milan Jagurinoski, Yanitsa Davidkova, Milena Stojcov-Jagurinoska, et al.
Folia Medica (2023) Vol. 65, Iss. 5, pp. 728-736
Open Access
The neuronal homeobox transcription factor HMX3 is a crucial vulnerability factor in MECOM-negative KMT2A::MLLT3 acute myelomonocytic leukemia
Saioa Arza-Apalategi, Branco M. H. Heuts, Saskia M. Bergevoet, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
PRMT5 regulates ATF4 transcript splicing and oxidative stress response
Magdalena M. Szewczyk, Genna M. Luciani, Victoria Vu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Inhibitory effect of trihydroxyisoflavone family for a candidate target MECOM for glioblastoma multiforme
D. Vidhya, P. Vanathi, Wathiq Mansoor, et al.
2022 Advances in Science and Engineering Technology International Conferences (ASET) (2022), pp. 1-4
Closed Access
Acute Myeloid Leukemia in Adults: Mast Cell Leukemia and Other Mast Cell Neoplasms
Richard M. Stone, Charles A. Schiffer, Daniel J. DeAngelo
Holland‐Frei Cancer Medicine (2022), pp. 1-21
Closed Access
Previous Page - Page 2

Scroll to top